FineTest
SKU:FNab10835
anti- CIP2A antibody
anti- CIP2A antibody
Couldn't load pickup availability
Unlock the mysteries of cancer biology and protein phosphatase regulation with our Anti-CIP2A Antibody, available in a 100µg size. Cancerous Inhibitor of PP2A (CIP2A) is a critical protein involved in modulating the activity of Protein Phosphatase 2A (PP2A), contributing to tumorigenesis and cancer progression.
This meticulously designed antibody offers unparalleled specificity and sensitivity, ensuring accurate detection of CIP2A protein in your experiments. Researchers investigating cancer signaling pathways, protein phosphorylation, or related areas will appreciate the precision and reliability of this antibody.
Our Anti-CIP2A Antibody undergoes rigorous quality control, guaranteeing consistent and reproducible results. Join the forefront of cancer research and gain valuable insights into the role of CIP2A in cancer development and therapeutic strategies.
Product Name
CIP2A antibody
Size
100µg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Host
Rabbit
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
BACKGROUND
Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellular protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellular signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several human malignancies including breast cancer, hepatocellular carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein.
IMMUNOGEN INFORMATION
Immunogen
KIAA1524
Synonyms
Cancerous inhibitor of PP2A, CIP2A, KIAA1524, p90, p90 autoantigen, Protein CIP2A
Observed MW
102 kDa
APPLICATION
Tested Application
ELISA, WB
Recommended Dilution
WB: 1:500 - 1:2000
UNIPROT INFORMATION
UniProt ID
IMAGES

HepG2 cells were subjected to SDS PAGE followed by western blot with FNab10835(CIP2A antibody) at dilution of 1:1000
Share
